231 related articles for article (PubMed ID: 20077564)
1. Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.
Knapp S; Warshow U; Hegazy D; Brackenbury L; Guha IN; Fowell A; Little AM; Alexander GJ; Rosenberg WM; Cramp ME; Khakoo SI
Hepatology; 2010 Apr; 51(4):1168-75. PubMed ID: 20077564
[TBL] [Abstract][Full Text] [Related]
2. A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.
Knapp S; Warshow U; Ho KM; Hegazy D; Little AM; Fowell A; Alexander G; Thursz M; Cramp M; Khakoo SI
Gastroenterology; 2011 Jul; 141(1):320-5, 325.e1-2. PubMed ID: 21600205
[TBL] [Abstract][Full Text] [Related]
3. Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.
Legrand N; David G; Rodallec A; Gaultier A; Salmon D; Cesbron A; Wittkop L; Raffi F; Gendzekhadze K; Retière C; Allavena C; Gagne K
Clin Exp Immunol; 2021 Apr; 204(1):107-124. PubMed ID: 33314121
[TBL] [Abstract][Full Text] [Related]
4. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
[TBL] [Abstract][Full Text] [Related]
5. IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.
Suppiah V; Gaudieri S; Armstrong NJ; O'Connor KS; Berg T; Weltman M; Abate ML; Spengler U; Bassendine M; Dore GJ; Irving WL; Powell E; Hellard M; Riordan S; Matthews G; Sheridan D; Nattermann J; Smedile A; Müller T; Hammond E; Dunn D; Negro F; Bochud PY; Mallal S; Ahlenstiel G; Stewart GJ; George J; Booth DR;
PLoS Med; 2011 Sep; 8(9):e1001092. PubMed ID: 21931540
[TBL] [Abstract][Full Text] [Related]
6. Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.
Vidal-Castiñeira JR; López-Vázquez A; Díaz-Peña R; Alonso-Arias R; Martínez-Borra J; Pérez R; Fernández-Suárez J; Melón S; Prieto J; Rodrigo L; López-Larrea C
J Virol; 2010 Jan; 84(1):475-81. PubMed ID: 19846535
[TBL] [Abstract][Full Text] [Related]
7. Association of killer cell immunoglobulin-like receptors with spontaneous clearance of hepatitis C virus in the Chinese population.
Shan Z; Huang J; Liao Q; Huang K; Wang M; Xu R; Tang X; Zhang W; Nelson K; Fu Y; Li C; Rong X
Transfusion; 2018 Apr; 58(4):1028-1035. PubMed ID: 29446443
[TBL] [Abstract][Full Text] [Related]
8. KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection.
Di Bona D; Aiello A; Colomba C; Bilancia M; Accardi G; Rubino R; Giannitrapani L; Tuttolomondo A; Cascio A; Caiaffa MF; Rizzo S; Di Lorenzo G; Candore G; Duro G; Macchia L; Montalto G; Caruso C;
J Viral Hepat; 2017 Sep; 24(9):768-775. PubMed ID: 28211154
[TBL] [Abstract][Full Text] [Related]
9. KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.
Thoens C; Berger C; Trippler M; Siemann H; Lutterbeck M; Broering R; Schlaak J; Heinemann FM; Heinold A; Nattermann J; Scherbaum N; Alter G; Timm J
J Hepatol; 2014 Sep; 61(3):475-81. PubMed ID: 24780303
[TBL] [Abstract][Full Text] [Related]
10. Sequence variations in HCV core-derived epitopes alter binding of KIR2DL3 to HLA-C∗03:04 and modulate NK cell function.
Lunemann S; Martrus G; Hölzemer A; Chapel A; Ziegler M; Körner C; Garcia Beltran W; Carrington M; Wedemeyer H; Altfeld M
J Hepatol; 2016 Aug; 65(2):252-8. PubMed ID: 27057987
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cell receptor variants and chronic hepatitis B virus infection in the Vietnamese population.
Auer ED; Tong HV; Amorim LM; Malheiros D; Hoan NX; Issler HC; Petzl-Erler ML; Beltrame MH; Boldt ABW; Toan NL; Song LH; Velavan TP; Augusto DG
Int J Infect Dis; 2020 Jul; 96():541-547. PubMed ID: 32422377
[TBL] [Abstract][Full Text] [Related]
12. Significant association of KIR2DL3-HLA-C1 combination with cerebral malaria and implications for co-evolution of KIR and HLA.
Hirayasu K; Ohashi J; Kashiwase K; Hananantachai H; Naka I; Ogawa A; Takanashi M; Satake M; Nakajima K; Parham P; Arase H; Tokunaga K; Patarapotikul J; Yabe T
PLoS Pathog; 2012; 8(3):e1002565. PubMed ID: 22412373
[TBL] [Abstract][Full Text] [Related]
13. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands.
Gendzekhadze K; Norman PJ; Abi-Rached L; Graef T; Moesta AK; Layrisse Z; Parham P
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18692-7. PubMed ID: 19837691
[TBL] [Abstract][Full Text] [Related]
14. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
[TBL] [Abstract][Full Text] [Related]
15. HLA-Bw4 80(T) and multiple HLA-Bw4 copies combined with KIR3DL1 associate with spontaneous clearance of HCV infection in people who inject drugs.
Thöns C; Senff T; Hydes TJ; Manser AR; Heinemann FM; Heinold A; Heilmann M; Kim AY; Uhrberg M; Scherbaum N; Lauer GM; Khakoo SI; Timm J
J Hepatol; 2017 Sep; 67(3):462-470. PubMed ID: 28412292
[TBL] [Abstract][Full Text] [Related]
16. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.
Khakoo SI; Thio CL; Martin MP; Brooks CR; Gao X; Astemborski J; Cheng J; Goedert JJ; Vlahov D; Hilgartner M; Cox S; Little AM; Alexander GJ; Cramp ME; O'Brien SJ; Rosenberg WM; Thomas DL; Carrington M
Science; 2004 Aug; 305(5685):872-4. PubMed ID: 15297676
[TBL] [Abstract][Full Text] [Related]
17. Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection.
Rauch A; Laird R; McKinnon E; Telenti A; Furrer H; Weber R; Smillie D; Gaudieri S;
Tissue Antigens; 2007 Apr; 69 Suppl 1():237-40. PubMed ID: 17445209
[TBL] [Abstract][Full Text] [Related]
18. Chimpanzee susceptibility to hepatitis C virus infection correlates with presence of Pt-KIR3DS2 and Pt-KIR2DL9: paired activating and inhibitory natural killer cell receptors.
Abi-Rached L; Guethlein LA; Norman PJ; Parham P
Immunogenetics; 2015 Oct; 67(10):625-8. PubMed ID: 26260270
[TBL] [Abstract][Full Text] [Related]
19. Protective KIR-HLA interactions for HCV infection in intravenous drug users.
Zúñiga J; Romero V; Azocar J; Terreros D; Vargas-Rojas MI; Torres-García D; Jiménez-Alvarez L; Vargas-Alarcón G; Granados-Montiel J; Husain Z; Chung RT; Alper CA; Yunis EJ
Mol Immunol; 2009 Aug; 46(13):2723-7. PubMed ID: 19552960
[TBL] [Abstract][Full Text] [Related]
20. Impact of HLA Allele-KIR Pairs on HIV Clinical Outcome in South Africa.
Mori M; Leitman E; Walker B; Ndung'u T; Carrington M; Goulder P
J Infect Dis; 2019 Apr; 219(9):1456-1463. PubMed ID: 30520960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
